Fingerprint
Dive into the research topics of 'Neuronatin is a modifier of estrogen receptor-positive breast cancer incidence and outcome'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Neuronatin is a modifier of estrogen receptor-positive breast cancer incidence and outcome
Cody Plasterer, Shirng Wern Tsaih, Amy R. Peck, Inna Chervoneva, Caitlin O’Meara, Yunguang Sun, Angela Lemke, Dana Murphy, Jennifer Smith, Sophia Ran, Albert J. Kovatich, Jeffrey A. Hooke, Craig D. Shriver, Hai Hu, Edith P. Mitchell, Carmen Bergom, Amit Joshi, Paul Auer, Jeremy Prokop, Hallgeir Rui
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
5
Scopus
citations